首页 | 本学科首页   官方微博 | 高级检索  
     

石见穿对肝癌H22荷瘤小鼠肿瘤生长的影响
引用本文:柳芳,刘建勋,李军梅,李鸿海,洪晓华. 石见穿对肝癌H22荷瘤小鼠肿瘤生长的影响[J]. 中国实验方剂学杂志, 2012, 18(12): 249-251
作者姓名:柳芳  刘建勋  李军梅  李鸿海  洪晓华
作者单位:1. 中国中医科学院西苑医院实验研究中心,北京100091;北京中医药大学,北京 100029
2. 中国中医科学院西苑医院实验研究中心,北京,100091
基金项目:国家重大新药创制专项(2009ZX09301-005-007)
摘    要:
目的:观察石见穿对肝癌H22小鼠肿瘤生长的影响,并探讨其可能的作用机制.方法:肝癌H22荷瘤小鼠随机分为5组:模型组、石见穿提取物高、中、低(40,10,2.5 g·kg-1 ig)3个剂量组和阳性药环磷酰胺(CTX,0.025 g·kg-1,ip)对照组.连续10d.于第11天观测抑瘤率、脾指数、胸腺指数、血清中肿瘤坏死因子-a(TNF-α)和血骨内皮细胞生长因子(VEGF)的含量.结果:与模型组比较,石见穿提取物高、中、低剂量组的抑瘤率分别为23.83%,48.93% (P <0.01)和27.48 (P<0.05);石见穿提取物中、低剂量组脾指数和胸腺指数升高,但差异无统计学意义;石见穿提取物各剂量组血清中TNF-α和VEGF含量下降,以中剂量组VEGF含量下降明显,模型组(28.64±7.18)pg·mL-1,中剂量组(21.22 +5.60)pg·mL-1(P<0.05).结论:石见穿提取物对肝癌H22荷瘤小鼠肿瘤的生长具有明显的抑制作用,其作用机制可能与下调细胞因子VEGF含量有关.

关 键 词:石见穿  肿瘤  肝癌H22  免疫
收稿时间:2012-03-07

Inhibitory Effect of Extracts from Salvia chinensis Against H22 Tumor in Mice
LIU Fang,LIU Jian-xun,LI Jun-mei,LI Hong-hai and HONG Xiao-hua. Inhibitory Effect of Extracts from Salvia chinensis Against H22 Tumor in Mice[J]. China Journal of Experimental Traditional Medical Formulae, 2012, 18(12): 249-251
Authors:LIU Fang  LIU Jian-xun  LI Jun-mei  LI Hong-hai  HONG Xiao-hua
Affiliation:Research and Development Center, Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091,China;Beijing University of Chinese Medicine, Beijing 100029,China;Research and Development Center, Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091,China;Research and Development Center, Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091,China;Research and Development Center, Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091,China;Research and Development Center, Xiyuan Hospital, China Academy of Chinese Medicine Sciences, Beijing 100091,China
Abstract:
Objective:To evaluate the inhibitory effect of extracts from Salvia chinensis against H22 tumor in mice,and analyze the mechanism of inhibiting the growth of tumor.Method: H22 tumor-bearing mice were randomly divided into five groups,they were control group,high,middle and low dosages of extracts from S.chinensis,and positive-control group.All the treatment lasted 10 days.We investigated the inhibition rate,spleen index,thymus index,content of tumor necrosis factor α(TNF-α) and vascular endothelial cell growth factor(VEGF) in serum at the 11th day.Result: In contrast to model group,the inhibition rate of the high,middle,and low dosages of S.chinensis extracts were 23.83%,48.93%(P<0.01) and 27.48(P<0.05),respectively.The spleen index and thymus index of middle and low dosages of S.chinensis extracts rose,but there was not statistical significance.The content of TNF-α and VEGF in serum of administered group were decreased,and the middle dosage of S.chinensis was remarkable(P<0.05).Conclusion: S.chinensis benth extracts could obviously inhibit tumor growth of H22 in tumor-bearing mice,and maybe it involved the down regulation of VEGF.
Keywords:Salvia chinensis  tumor  hepatoma H22  immune
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号